Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes

Diabetologia

Volumn 59, Issue 3, 2016, Pages 492-501

  Krogvold, Lars ^a,b   Wiberg, Anna ^c   Edwin, Bjørn ^a,b   Buanes, Trond ^b,d   Jahnsen, Frode Lars ^a,b   Hanssen, Kristian F ^a,b   Larsson, Erik ^c   Korsgren, Olle ^c   Skog, Oskar ^c   Dahl Jørgensen, Knut ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Gene expression; Inflammation; Insulin; Insulitis; Pancreas; T cells; Type 1 diabetes

Indexed keywords

CD3 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INSULIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTOME;

ADULT; ARTICLE; B LYMPHOCYTE; CELL DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; INSULITIS; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; LASER CAPTURE MICRODISSECTION; LYMPHOCYTIC INFILTRATION; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; BLOOD; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNOLOGY; MALE; METABOLISM; PANCREAS; PHYSIOLOGY; YOUNG ADULT;

ADULT; B-LYMPHOCYTE SUBSETS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; MALE; PANCREAS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84957437395     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3820-4     Document Type: Article

References (33)

1. Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368
2. Atkinson MA (2012) The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2:1–18
3. Matveyenko AV, Butler PC (2008) Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 10(Suppl 4):23–31
4. Klinke DJ (2011) Age-corrected beta cell mass following onset of type 1 diabetes mellitus correlates with plasma C-peptide in humans. PLoS One 6:e26873
5. In't Veld P (2014) Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol 36:569–579
6. Schmidt MB (1902) Ueber die beziehung der Langerhanschen inseln des pankreas zum diabetes mellitus. Munch Med Wochenschr 49:51–54, article in German
7. Von Meyenburg M (1940) Ueber “insulitits” bei diabetes. Schweiz Med Wochenschr 21:554–557, article in German
8. Campbell-Thompson ML, Atkinson MA, Butler AE et al (2013) The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56:2541–2543
9. Krogvold L, Edwin B, Buanes T et al (2014) Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 57:841–843
10. Krogvold L, Edwin B, Buanes T et al (2015) Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64:1682–1687
11. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274
12. Marselli L, Sgroi DC, Bonner-Weir S, Weir GC (2009) Laser capture microdissection of human pancreatic beta-cells and RNA preparation for gene expression profiling. Methods Mol Biol 560:87–98
13. Skog O, Korsgren S, Wiberg A et al (2015) Expression of human leukocyte antigen class I in endocrine and exocrine pancreatic tissue at onset of type 1 diabetes. Am J Pathol 185:129–138
14. Korsgren S, Molin Y, Salmela K, Lundgren T, Melhus A, Korsgren O (2012) On the etiology of type 1 diabetes: a new animal model signifying a decisive role for bacteria eliciting an adverse innate immunity response. Am J Pathol 181:1735–1748
15. Goto M, Eich TM, Felldin M et al (2004) Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 78:1367–1375
16. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633
17. Oram RA, Jones AG, Besser RE et al (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57:187–191
18. Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59:2846–2853
19. In't Veld P (2011) Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 3:131–138
20. Pipeleers D, Ling Z (1992) Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209–227
21. Gale EA (2001) The discovery of type 1 diabetes. Diabetes 50:217–226
22. Reddy S, Zeng N, Al-Diery H et al (2015) Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients. Diabetologia 58:1024–1035
23. Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51–60
24. Skowera A, Ladell K, McLaren JE et al (2015) Beta-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes 64:916–925
25. Bulek AM, Cole DK, Skowera A et al (2012) Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol 13:283–289
26. Abreu JR, Martina S, Verrijn Stuart AA et al (2012) CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin Exp Immunol 170:57–65
27. Wooldridge L, Ekeruche-Makinde J, van den Berg HA et al (2012) A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 287:1168–1177
28. Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890
29. Staeva-Vieira T, Peakman M, von Herrath M (2007) Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol 148:17–31
30. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H et al (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361:2143–2152
31. Keymeulen B, Walter M, Mathieu C et al (2010) Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 53:614–623
32. Herold KC, Gitelman S, Greenbaum C et al (2009) Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin Immunol 132:166–173
33. Eizirik DL, Sammeth M, Bouckenooghe T et al (2012) The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 8, e1002552